Medivir AB (publ) (MVIR.ST)

Sweden · Healthcare · SEK

Key financials

ROE: -69.74%; 2025 (actual)
ROA: -51.06%; 2025 (actual)
Gross Margin: 100%; 2025 (actual)
Net Margin: -
Total Assets: SEK 197,193.00K; 2025 (actual)
Net Income: -SEK 94,400.00K; 2025 (actual)
Valuation: SEK 255,289.39K; 2026 (forecast)
Stock Price: SEK 0.41; 2026 (forecast)

Historical & projected performance

Reported figures and Equlion model projections for the next 5 years.

Metric	2025 (actual)	2026 (forecast)	2027	2028	2029	2030	2031
ROE	-69.74%	-33.59%	-26.96%	-41.71%	-88.49%	-	110.65%
ROA	-51.06%	-28.67%	-22.28%	-24.87%	-26%	-25.87%	-25.72%
Gross Margin	100%	100%	100%	100%	100%	100%	100%
Sector average	-	17.71%	17.71%	17.71%	17.71%	17.71%	62.35%
Total Assets	SEK 197,193.00K

Amounts in SEK (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2026. Projections are model estimates, not investment advice.

Want the full financial forecast report for Medivir AB (publ)? It covers the balance sheet, income statement and Equlion model projections.

Net Income	-SEK 94,400.00K	-SEK 75,740.00K	-SEK 70,266.31K	-SEK 77,833.24K	-SEK 90,608.82K	-SEK 100,259.67K	-SEK 106,915.80K
Sector average	-	-SEK 22,027.28K	-SEK 904.69K	-SEK 7,253.84K	-SEK 3,858.45K	-SEK 1,547.00K	-SEK 13,704.11K

Valuation	-	SEK 255,289.39K	SEK 236,839.75K	SEK 262,344.88K	SEK 305,406.27K	SEK 337,935.42K	SEK 360,370.62K
Sector average	-	SEK 5,151,301.60K	SEK 5,189,236.02K	SEK 5,317,343.69K	SEK 5,514,329.75K	SEK 5,636,782.17K	SEK 3,179,755.44K

Stock Price	-	SEK 0.41	SEK 0.38	SEK 0.42	SEK 0.49	SEK 0.54	SEK 0.58
Sector average	-	SEK 48.04	SEK 48.69	SEK 50.45	SEK 52.13	SEK 53.41	SEK 36.70